Skip to main content
. 2016 Sep 1;2016(9):CD011440. doi: 10.1002/14651858.CD011440.pub2

3.

3

In the control group, 25 people out of 100 had exacerbations over 52 weeks, compared to 17 (95% CI 13 to 22) out of 100 for the active treatment group. NNTB 12 (95% CI 8 to 32).